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A B S T R A C T
Background: In Parkinson's disease (PD), the relation between cortical brain atrophy on MRI and clinical pro-
gression is not straightforward. Determination of changes in structural covariance networks - patterns of cov-
ariance in grey matter density - has shown to be a valuable technique to detect subtle grey matter variations. We
evaluated how structural network integrity in PD is related to clinical data.
Methods: 3 Tesla MRI was performed in 159 PD patients. We used nine standardized structural covariance
networks identified in 370 healthy subjects as a template in the analysis of the PD data. Clinical assessment
comprised motor features (Movement Disorder Society-Unified Parkinson's Disease Rating Scale; MDS-UPDRS
motor scale) and predominantly non-dopaminergic features (SEverity of Non-dopaminergic Symptoms in
Parkinson's Disease; SENS-PD scale: postural instability and gait difficulty, psychotic symptoms, excessive
daytime sleepiness, autonomic dysfunction, cognitive impairment and depressive symptoms). Voxel-based
analyses were performed within networks significantly associated with PD.
Results: The anterior and posterior cingulate network showed decreased integrity, associated with the SENS-PD
score, p = 0.001 (β=−0.265, ηp2 = 0.070) and p = 0.001 (β= −0.264, ηp2 = 0.074), respectively. Of the
components of the SENS-PD score, cognitive impairment and excessive daytime sleepiness were associated with
atrophy within both networks.
Conclusions: We identified loss of integrity and atrophy in the anterior and posterior cingulate networks in PD
patients. Abnormalities of both networks were associated with predominantly non-dopaminergic features, spe-
cifically cognition and excessive daytime sleepiness. Our findings suggest that (components of) the cingulate
networks display a specific vulnerability to the pathobiology of PD and may operate as interfaces between
networks involved in cognition and alertness.
1. Introduction
Parkinson's disease (PD) is characterized by a broad spectrum of
motor and non-motor features. It has been proposed that widespread
pathological changes (Lewy bodies and Lewy neurites) in select nuclei
of the central and peripheral nervous system underlie the complex
clinical presentation of PD (Jellinger, 2012). Increasing evidence points
at the existence of a coherent grouping of some of the clinical domains,
which largely involve symptoms that do not improve on dopaminergic
medication. The grouping of these symptoms is present early in the
disease course (Van der Heeden et al., 2016), worsens over time (Van
der Heeden et al., 2016), and probably reflects advancing Lewy body
pathology in the nervous system (Adler and Beach, 2016).
Previous anatomical magnetic resonance imaging (MRI) studies
commonly investigated voxel-wise differences in regional grey matter
volume between PD patients and control subjects. These studies re-
vealed reduced grey matter in patients (Pan et al., 2012), which,
however, is nonspecific to PD. Further, the findings are inconsistent
across studies (Pan et al., 2012), which is likely explained by the clin-
ical heterogeneity of PD and the current insensitivity of imaging
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techniques to detect subtle changes in brain structures. New techniques
including computational network-based analyses are increasingly im-
portant in uncovering in vivo patterns of brain atrophy not readily
apparent by regional structural analysis (Alexander-Bloch et al., 2013;
Hafkemeijer et al., 2016). Evidence suggests that anatomical structures
that are spatially distributed but functionally linked, co-vary in grey
matter density (structural covariance networks; SCNs) within in-
dividuals across a population (Alexander-Bloch et al., 2013; Andrews
et al., 1997).
Factors like age and disease affect SCNs (Hafkemeijer et al., 2014;
Möller et al., 2015). Distinct aging effects on the organization of SCNs
were demonstrated in healthy elderly (Montembeault et al., 2012;
Spreng and Turner, 2013). Also, it was shown that Alzheimer's disease
and frontotemporal dementia have specific SCNs of degeneration
(Hafkemeijer et al., 2016). These findings support that this metho-
dology may have the potential to identify brain regions within disease
specific structural networks that confer a preferential vulnerability to
the pathobiology of PD.
In this study, we studied SCN integrity in PD patients. We evaluated
whether the integrity of SCNs - constructed from grey matter density in
healthy elderly adults, is associated with clinical severity of PD and if
the integrity is associated with predominantly dopaminergic or non-
dopaminergic symptoms.
2. Materials and methods
2.1. Study design and participants
PD patients were recruited from the outpatient clinic for Movement
Disorders of the Department of Neurology of the LUMC (Leiden
University Medical Center) and nearby university and regional hospi-
tals. All participants fulfilled the United Kingdom Parkinson's Disease
Society Brain Bank criteria for idiopathic PD (Gibb and Lees, 1988). The
present study is a cross-sectional cohort study of PD patients and is part
of the ‘PROfiling PARKinson's disease’ (PROPARK) study. Written
consent was obtained from all participants. The Medical Ethics Com-
mittee of the LUMC approved the study.
2.2. Clinical assessments
All patients underwent standardized assessments, including an
evaluation of demographic and clinical characteristics. Participants
were tested while on-medication, except for 24 patients (22 de novo
patients, defined as dopaminergic drug-naïve patients with a disease
duration shorter than five years; two other dopaminergic drug-naïve
patients). The MDS-UPDRS motor scale (part III) was used to quantify
the severity of motor symptoms (Goetz et al., 2008). The SENS-PD
(SEverity of Non-dopaminergic Symptoms in Parkinson's Disease) scale
is a composite score comprising three items with four response options
(0–3) from each of the following six predominantly non-dopaminergic
domains: postural instability and gait difficulty, psychotic symptoms,
excessive daytime sleepiness, autonomic dysfunction, cognitive im-
pairment and depressive symptoms (total range: 0–54) (van der Heeden
et al., 2014; Van der Heeden et al., 2016). These six domains represent
a coherent complex of symptoms that is already present in the early
disease stages and increases in severity when the disease advances. The
SENS-PD is a recently developed short, reliable and valid scale that
includes symptoms that do not improve with dopaminergic medication
and its score may therefore more accurately reflect severity and pro-
gression of the underlying disease than currently used dopamine-sen-
sitive measures. Higher scores on both scales reflect more severe im-
pairment. Trained research associates administered the MDS-UPDRS
motor scale and the ‘postural instability and gait difficulty’, ‘psychotic
symptoms’ and ‘cognitive impairment’ items of the SENS-PD scale. The
‘excessive daytime sleepiness’, ‘autonomic dysfunction’ and ‘depressive
symptoms’ items were self-completed by patients. A levodopa dose
equivalent (LDE) of daily levodopa and dopamine agonists dose was
calculated for each patient. The total LDE is the sum of levodopa dosage
equivalent (LDE-Dopa) and the dopamine agonist dosage equivalent
(LDE-DA) (Tomlinson et al., 2010).
2.3. MRI acquisition
Three-dimensional T1-weighted anatomical images were acquired
on a 3 Tesla MRI scanner (Philips Achieva, Best, the Netherlands) using
a standard 32-channel whole-head coil. Acquisition parameters were:
repetition time = 9.8 ms, echo time = 4.6 ms, flip angle = 8°, field of
view 220 × 174 × 156 mm, 130 slices with a slice thickness of 1.2 mm
with no gap between slices, resulting in a voxel size of
1.15 mm× 1.15 mm× 1.20 mm.
2.4. Data analysis
Before analysis, all MRI scans were visually checked to ensure that
no major artifacts or abnormalities were present in the data. All ana-
lyses were done using the software provided by FSL (FMRIB's software
library, version 5.0.8, Oxford, United Kingdom) (Smith et al., 2004).
2.5. Pre-processing
The 3DT1 images were pre-processed using the pre-processing steps
used for voxel-based morphometric analysis (Douaud et al., 2007; Good
et al., 2001; Smith et al., 2004). Each step was visually checked. The
T1-weighted images were brain-extracted and tissue-type segmentation
was performed, resulting in probability maps of a given tissue type (i.e.
grey matter, white matter or cerebrospinal fluid). The grey matter
images were non-linearly registered to the 2 mm Montreal Neurological
Institute (MNI) 152 standard space (Montreal Neurological Institute,
Montreal QC, Canada) (Andersson et al., 2007; Jenkinson et al., 2002).
The resulting images were averaged to create a study-specific grey
matter template. All native grey matter images were subsequently non-
linearly re-registered to the study-specific grey matter template and
‘modulated’ to correct for local expansions or contractions due to the
non-linear component of the spatial transformation. The images were
smoothed with an isotropic Gaussian kernel with a sigma of 3 mm. The
modulated grey matter images in MNI space were concatenated into a
four-dimensional data set, which was used for the network and voxel-
based morphometry (VBM) analyses.
2.6. Structural covariance networks
We used nine bilateral standardized SCNs, identified in 370 healthy
elderly with an age range of 45–85 years, which is the same as the age
range in our PD population. For detailed information on the networks
see Hafkemeijer et al. (2014). The networks were derived using an in-
dependent component analysis, a statistical technique that defines
spatial component maps of maximal statistical independence. It is
commonly used to study functional network integrity, but it can also be
used to study if brain structures of a population co-vary in grey matter
volume (Hafkemeijer et al., 2014; Segall et al., 2012). The four-di-
mensional data set of grey matter images derived from our PD popu-
lation was used in a spatial regression against the nine SCN probability
maps (a general linear model approach integrated in FSL) (Filippini
et al., 2009). This way individual SCN integrity scores were calculated.
The integrity score is the beta coefficient of the regression analysis. It
can be a negative or a positive score, reflecting the strength of the in-
dividual expression in each network, with high scores indicating strong
individual expression of the network. To allow comparisons of the SCNs
of the template and patients with PD, identification of the nine SCNs in
patients with PD was conducted using the same approach as
Hafkemeijer et al. (2014). An independent component analysis was
applied on the four-dimensional data set of modulated grey matter
L.J. de Schipper et al. NeuroImage: Clinical 15 (2017) 587–593
588
images of all PD patients, using multivariate exploratory linear opti-
mized decomposition into independent components (Beckmann et al.,
2005). The independent component analysis was restricted to nine
components, the same amount as in the study of Hafkemeijer et al.
(2014). Significance of individual voxels within a spatial map was de-
rived using a mixture model, with a standard threshold level of 0.5
(Smith et al., 2004), which indicates an equal loss is placed on false
positives and false negatives.
2.7. Voxel-based morphometry
To investigate group differences in grey matter volume, a voxel-wise
general linear model in FSL was used. Grey matter region-of-interest
masks were obtained by identifying anatomical structures that were
present in the SCNs (Hafkemeijer et al., 2014). A design matrix was
constructed for estimating the relationship between grey matter volume
(in each region-of-interest) and clinical measures. Gender, age and
disease duration were used as covariates to correct for confounding
effects. The voxel-wise general linear model was applied on the pre-
viously derived four-dimensional data set. ‘Randomise’, FSL's tool for
nonparametric permutation inference on neuroimaging data, was used
with 5000 permutations to perform non-parametric statistics (Winkler
et al., 2014). We used the TFCE (Threshold-Free Cluster Enhancement)
technique to correct for multiple comparisons (Smith and Nichols,
2009).
Brain structures were identified using the Harvard-Oxford atlas in-
tegrated in FSL.
2.8. Statistical analysis
Differences in age and gender between patients and control subjects
in which the template was defined, were analyzed with an independent-
sample t-test (age) and a chi-square test (gender). The relationship
between SCN integrity and clinical measures was investigated using
general linear modeling within the PD group, adjusted for gender, age
and disease duration. Associations were studied between SCN integrity
scores (dependent variable) and the MDS-UPDRS motor score, and
between SCN integrity scores and the SENS-PD score. Bonferroni cor-
rection was applied to account for multiple comparisons (p-value: 0.05/
18 = 0.003). If the integrity score of a network showed a statistically
significant association with the MDS-UPDRS motor score or the SENS-
PD score, we examined associations between the SCN integrity score
and the domains scores of the concerning clinical scale. A Bonferroni
correction was applied across the different networks (p-value = 0.05/
amount of items of the concerning clinical score, i.e. six domains of the
SENS-PD and four of the MDS-UPDRS motor score). To investigate
whether dosage of dopaminergic medication could affect structural
networks, we examined associations between the SCN integrity scores
and LDE scores within the PD group who used dopaminergic medica-
tion. To study group differences between de novo patients and patients
who used dopaminergic medication, we performed additional general
linear modeling analyses in which network integrities were treated as
dependent variables and the group (de novo patients or patients who
used dopaminergic medication) as an independent, fixed, variable,
while adjusting for age and gender. SPSS version 23.0 was used for all




159 patients were included in the analysis. Demographic and clin-
ical data of all participants are shown in Table 1.
3.2. Structural covariance network integrity
Of the nine SCNs, the integrity of the posterior and anterior cin-
gulate network (SCN c and d) both showed a negative association with
the SENS-PD score (p = 0.001 and p = 0.001, respectively; Table 2).
The integrity of the anterior cingulate network showed a negative as-
sociation with the MDS-UPDRS motor score (p = 0.032). After correc-
tion for multiple comparisons, the associations between the posterior
and anterior cingulate network and the SENS-PD score remained sig-
nificant (Table 2).
As the associations between the posterior and anterior cingulate
network and the total SENS-PD score were significant, the associations
between SCN integrity of the cingulate networks and the domain scores
of the SENS-PD scale (postural instability and gait difficulty, cognitive
impairment, depressive symptoms, psychotic symptoms, excessive
daytime sleepiness and autonomic symptoms) were subsequently
tested. The SCN integrity scores of the posterior and anterior cingulate
network were negatively associated with cognitive impairment (pos-
terior cingulate network: β = −0.309, p < 0.001, ηp2 = 0.097;
anterior cingulate network: β = −0.162, p = 0.049, ηp2 = 0.026) and
excessive daytime sleepiness (posterior cingulate network:
β = −0.172, p = 0.021, ηp2 = 0.034; anterior cingulate network:
β = −0.213, p = 0.005, ηp2 = 0.051). After correction for multiple
comparisons, the association between the posterior cingulate network
and cognitive impairment remained significant. The association be-
tween the anterior cingulate network and EDS remained significant as
well. No significant associations were found between the SCN integrity
and the domain scores of postural instability and gait difficulty, de-
pressive symptoms, psychotic symptoms and autonomic symptoms. The
associations between SCN integrity and the different domain scores of
the MDS-UPDRS motor scale (i.e., tremor, rigidity, bradykinesia and
postural instability and gait difficulty) were not tested because no sig-
nificant associations were found between SCN integrity scores and the
total MDS-UPDRS motor score after correction for multiple compar-
isons. We found that LDE score was not associated with SCN integrity
scores. For none of the nine SCNs, a significant group difference in SCN





N 159 370 p-Value





Age, year, mean (SD) 64.9 (7.1) 65.7 (6.7) 0.234
Disease duration, year, mean (SD) 9.1 (4.8)
MDS-UPDRS motor score, mean (SD)
(0−132)
34.3 (15.7)
SENS-PD, mean (SD), n = 153 (0–54) 13.0 (6.1)
MMSE, mean (SD), n = 156 (0−30) 28.4 (1.8)




De novo patientsa, n = 22 –
LDE-Dopa, mg/day 735.1 (507.5)
LDE-DA dose, mg/day 198.0 (216.7)
For all measurement instruments, the score range is presented in parentheses. SD: stan-
dard deviation; MDS-UPDRS: Movement Disorder Society-Unified Parkinson's Disease
Rating Scale; SENS-PD: SEverity of Non-dopaminergic Symptoms in Parkinson's Disease;
MMSE: Mini Mental State Examination; LDE: Levodopa dosage equivalent; DA: dopamine
agonists.
a De novo patients were defined as dopaminergic drug-naïve patients with a disease
duration shorter than five years.
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3.3. Voxel-based analyses
Loss of integrity in a SCN is due to grey matter changes in one or
more component(s) in the network. To detect which components were
specifically atrophied, voxel-based analysis within the posterior and
anterior cingulate network was performed. We used the domain score
of cognitive impairment to examine decreased grey matter in the pos-
terior cingulate network and excessive daytime sleepiness to examine
decreased grey matter in the anterior cingulate network, as is shown in
Fig. 1. Large clusters of grey matter volume reductions in the posterior
cingulate network related to cognitive impairment were localized in the
posterior cingulate cortex (p = 0.002, peak cluster MNI coordinates: 0,
−52, 24, voxel size = 509) and the central operculum cortex
(p < 0.001, peak cluster MNI coordinates: 54, −2, 4, voxel
size = 786). Smaller clusters of decreased grey matter were found in
the subcallosal cortex (p = 0.015, peak cluster MNI coordinates: 0, 16,
−12, voxel size = 103), the parietal operculum cortex (p = 0.046,
peak cluster MNI coordinates: 38, −22, 18, voxel size = 21) and the
posterior middle temporal gyrus (p = 0.020, peak cluster MNI co-
ordinates: −58, −34, −10, voxel size = 28). In the anterior cingulate
network, decreased grey matter related to excessive daytime sleepiness
was found in the middle frontal gyrus (p = 0.014, peak cluster MNI
coordinates: 36, 16, 48, voxel size = 191), the frontal medial cortex
(p = 0.007, peak cluster MNI coordinates: −4, 52, −20, voxel
size = 252) and the cuneus (p = 0.013, peak cluster MNI coordinates:
2, −86, 18, voxel size = 178).
3.4. Cingulate networks in patients with PD
To visualize the abnormal architecture of both cingulate SCNs, the
networks were also defined in all patients with PD. As is shown in
Fig. 2, some components of the cingulate networks identified in healthy
control subjects are missing in the networks identified in patients with
PD. These missing components do not significantly co-vary in grey
matter density with the network. The most prominent changes are seen
in the anterior (Fig. 2A and B) and posterior cingulate cortex (Fig. 2A)
and the frontal medial cortex (Fig. 2B).
4. Discussion
Within individuals across a population, spatially distributed regions
of the brain, which are functionally linked, may show a structural
covariance of grey matter volume. Although the neurobiological un-
derpinnings of SCNs and functional covariance network associations are
unclear, it has been posited that SCNs reflects shared long-term trophic
influences within functionally synchronous systems (Zielinski et al.,
2010). Recently, nine SCNs were established in 370 healthy elderly
(Hafkemeijer et al., 2014). In four out of nine SCNs (subcortical net-
work, sensorimotor network, posterior cingulate network, anterior
cingulate network), grey matter volume decreased with advancing age.
Given the important role of age in the development and prognosis of
PD, we examined the influence of PD on the topological organization of
nine SCNs established in healthy elderly. Our study led to two main
findings: (1) only the anterior and posterior cingulate SCN showed a
loss of integrity beyond the effects of aging; (2) the reduced integrity of
both cingulate SCNs was significantly associated with predominantly
non-dopaminergic domains, including cognitive impairment and ex-
cessive daytime sleepiness.
To unravel if specific regions that make up the SCNs explained the
clinical associations, we studied grey matter changes within both net-
works in relation to these two predominantly non-dopaminergic do-
mains. The largest clusters of decreased grey matter were found in re-
lation to cognitive impairment in two regions of the posterior cingulate
network: central operculum cortex and posterior cingulate cortex.
Compared to cognitive impairment, smaller clusters of decreased grey
matter, albeit still significant associations, were found for excessive
Table 2
Associations between the SCN integrity scores and the composite clinical measures (MDS-UPDRS motor scale; SENS-PD scale).
Predominant brain region in SCN MDS-UPDRS motor score SENS-PD score
Beta p-Value (ηp2) Beta p-Value (ηp2)
SCN a Thalamus −0.052 0.511 (0.003) 0.040 0.617 (0.002)
SCN b Lateral occipital cortex −0.075 0.348 (0.006) −0.052 0.520 (0.003)
SCN c Posterior cingulate cortex −0.155 0.052 (0.024) −0.264 0.001 (0.074)⁎
SCN d Anterior cingulate cortex −0.172 0.032 (0.030) −0.265 0.001 (0.070)⁎
SCN e Temporal pole −0.071 0.418 (0.004) −0.025 0.785 (0.001)
SCN f Putamen 0.012 0.879 (0.000) 0.024 0.769 (0.001)
SCN g Cerebellum 0.094 0.260 (0.008) 0.087 0.311 (0.007)
SCN h Cerebellum 0.119 0.156 (0.013) 0.014 0.868 (0.000)
SCN i Cerebellum 0.012 0.891 (0.000) 0.037 0.677 (0.001)
SCN: structural covariance network; MDS-UPDRS: Movement Disorder Society-Unified Parkinson's Disease Rating Scale; SENS-PD: SEverity of Non-dopaminergic Symptoms in Parkinson's
Disease.
Beta: standardized β; ηp2: partial eta squared.
⁎ p-Value remained significant after correction for multiple comparisons. All analyses were adjusted for age, gender and disease duration.
Fig. 1. Regional grey matter changes in PD patients.
Red: Reduced grey matter in the posterior cingulate net-
work related to cognitive impairment. Yellow: Reduced
grey matter in the anterior cingulate network related to
excessive daytime sleepiness. Images are overlaid on the
most informative sagittal, coronal and transversal slices of
the MNI (Montreal Neurological Institute) standard anato-
mical image (MNI coordinates are −2, 18, 12). Results
with a Threshold-free cluster enhancement (TFCE)-Family
wise error (FWE) corrected p-value < 0.05 and a voxel
size above 30 are shown. (For interpretation of the refer-
ences to color in this figure legend, the reader is referred to
the web version of this article.)
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daytime sleepiness in three regions of the anterior cingulate network:
frontal medial cortex, middle frontal gyrus and cuneus. Collectively,
these findings are in line with those of others indicating a role of the
cingulate cortex in mediating processes involved in cognition and vig-
ilance in patients with PD (Leech and Sharp, 2014; Menon and Uddin,
2010; Zielinski et al., 2010).
Cognitive impairment is an important non-motor feature of PD,
which reflects the variable and interacting dysfunction in a number of
diffusely distributed, yet interrelated, neural networks that contribute
to distinct cognitive processes (Gratwicke et al., 2015). Compelling
evidence shows that structural and functional abnormalities of the
posterior cingulate cortex are found in neurological and psychiatric
diseases, e.g. Alzheimer's disease, schizophrenia, autism, depression
and attention deficit hyperactivity disorder (Leech and Sharp, 2014).
Congruent with results of other studies in PD, our study shows that
abnormalities of the posterior cingulate cortex are associated with
cognitive impairment (Christopher et al., 2015; Leech and Sharp,
2014).
In PD, excessive daytime sleepiness has been found associated with
various clinical factors, including cognitive impairment, postural in-
stability and gait difficulty, hallucinations, advanced disease, and do-
paminergic medication (Tholfsen et al., 2015; Zhu et al., 2016). The
neurological substrates of excessive daytime sleepiness are in-
completely understood, but likely involve extended subcortical-cortical
networks acting to promote arousal and sleep (Brown et al., 2012). The
anterior cingulate network shows spatial overlap with the functional
connectivity salience network (Seeley et al., 2007). The salience net-
work is considered to be involved in the integration of internal and
external stimuli, supporting the association we found with excessive
daytime sleepiness (Seeley et al., 2007). Our findings showing
Fig. 2. Cingulate networks defined in healthy control sub-
jects and in patients.
Both cingulate networks defined in healthy control subjects
and in patients with Parkinson's disease, overlaid on the
most informative sagittal, coronal and transversal slices of
the MNI (Montreal Neurological Institute) standard anato-
mical image (MNI coordinates are 8,−14, 20). A: Posterior
cingulate network. B: Anterior cingulate network.
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involvement of multiple regions of the anterior cingulate network, are
congruent with those of two other studies showing cortical atrophy of
occipital and frontal brain regions in PD patients with excessive day-
time sleepiness as compared to PD patients without excessive daytime
sleepiness (Gama et al., 2010; Kato et al., 2012).
Our patients had mild to moderate disease severity and a mean
disease duration of approximately nine years. In PD, cortical α-synu-
clein aggregation occurs in advanced stages and except for the cingulate
gyrus, neocortical regions have low frequencies of α-synuclein ag-
gregation (Beach et al., 2009; Jellinger, 2012). However, the functional
consequences of α-synuclein aggregation in the brain are unclear and
Braak stages are not related to clinical severity of PD (Schulz-Schaeffer,
2010). Recent evidence proposes that diverse molecular and cellular
pathologies involved in PD can give rise to common patterns of dys-
function at the neural systems level (Gratwicke et al., 2015).
The finding that reduced anterior and posterior cingulate network
integrity is associated with two different categories of predominantly
non-dopaminergic symptoms, may suggest that (components) of both
SCNs act as an integrative hub. Indeed, it is suggested that both the
anterior and posterior cingulate cortex may operate as important in-
terfaces between different functional networks involved in cognition
and alertness (Leech and Sharp, 2014; Menon and Uddin, 2010). Cog-
nition and alertness are regulated by large-scale functional networks,
consisting of numerous interconnected brain areas, which act (dyna-
mically) in concert to perform the circumscribed functions (Leech and
Sharp, 2014; Seeley et al., 2007). These large-scale brain networks
comprise cortical and subcortical areas and their interconnecting
structural or functional connections. Some brain areas perform im-
portant integrative roles in networks (hubs) because they display an
unusually high degree of intermodular connectivity which is not critical
to distinctive functions of the brain (van den Heuvel et al., 2013).
Findings from a human brain structural connectivity study using dif-
fusion imaging and tractography suggest that damage to hub regions
has a larger disruptive effect on network communication than damage
to non-hub regions of a network (van den Heuvel et al., 2013). This
finding may explain why damage of two cingulate structural networks
is associated with important dysfunctions on the level of cognition and
vigilance.
4.1. Strengths and limitations
The strength of this study lies in detecting grey matter changes with
a novel network-based technique in a large group of clinically well-
characterized PD patients with simultaneous acquired MR images.
Limitations of our study are related to the cross-sectional design. A
longitudinal design is preferable to assess the relationship between
network integrity and disease progression. Further, our population is
characterized by patients with mild to moderate disease severity, lim-
iting the generalizability of the results to the PD population at large.
Nonetheless, it is notable that even in these patients SCN analysis was
able to detect distinct regions of grey matter atrophy, which were re-
lated to severity of predominantly non-dopaminergic symptoms in two
domains. Patients were tested while on dopaminergic medication. In
addition, the depression scale (the Hospital Anxiety and Depression
Scale) (Zigmond and Snaith, 1983), from which items for the depres-
sion domain of the SENS-PD were taken, inquires after symptoms in the
last week and was completed in the week before the MRI was made,
when patients took their regular medication. We cannot rule out that
this may have resulted in a decrease of symptom scores that show some
sensitivity to dopaminergic influences and possibly have attenuated the
examined associations. This likely played a less prominent role with
regard to the total SENS-PD scale, which includes symptoms that
mainly do not improve with dopaminergic medication, although there
are potentially some positive effects on depression (Chaudhuri and
Schapira, 2009).
4.2. Conclusions
In conclusion, SCN analysis in mild to moderate PD revealed a loss
of integrity of the anterior and posterior cingulate SCN, which in turn
was explained by grey matter loss in specific brain regions within the
networks. The identified structural changes were associated with cog-
nitive impairment and excessive daytime sleepiness, suggesting that
components of both cingulate SCNs may operate as important interfaces
between different functional networks involved in cognition and
alertness.
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